Abstract
Measurement of blood levels of total cholesterol and lipoproteins (HDL and LDL) were conducted on 96 men with spinal cord injury, 46 paraplegics and 50 quadriplegics. All these patients were studied in the stabilized phase of the disease as a follow up to the rehabilitation process. The study was designed to compare results with a normal, able bodied population and to investigate if any abnormal finding could be related to the age at onset of the spinal cord injury, the duration of the disease or the level of the lesion.
Compared to the normal, able bodied population, this study indicates that patients with a spinal cord injury do not have higher levels of cholesterol or LDL, nor lower levels of HDL. Levels of total cholesterol increase with aging, as in the normal population, but have no relation to the duration of the disease or the level of the lesion. Blood levels of HDL and LDL do not seem to be related either to the duration of the disease or to the level of the lesion.
Similar content being viewed by others
Article PDF
References
Heldenberg D, Rubinstein A, Levtov O, Werbin B, Tamir I (1981) Serum lipids and lipoprotein concentrations in young quadriplegic patients. Atherosclerosis 39: 163–167.
Vaziri N D, Gordon S and Nikakhtar B (1982) Lipid abnormalities in chronic renal failure associated with spinal cord injury. Paraplegia 20: 183–189.
LaPorte R E, Brenes G, Dearwater S, Murphy M A, Cauley J A, Dietrick R et al (1983) HDL cholesterol across a spectrum of physical activity from quadriplegia to marathon running. (Letters to the Editor.) Lancet 1: 1212.
LaPorte R E, Adams L L, Savage D D, Brenes G, Dearwater S, Cook T (1984) The Spectrum of physical activity, cardiovascular disease and health: An epidemiologic perspective. (Reviews and Commentary.) J Epidemiol 120: 507–517.
Dearwater S R, LaPorte R E, Robertson R J, Brenes G, Adams L L, Becker D (1986) Activity in the spinal cord-injured patient: an epidemiologic analysis of metabolic parameters. Med Sci Sports Exerc 18: 541–544.
Brenes G, Dearwater S, Shapera R, LaPorte R E, Collins E (1986) High density lipoprotein cholesterol concentrations in physical active and sedentary spinal cord injured patients. Arch Phys Med Rehabil 67; 445–450.
Goldbourt U and Medalie J H (1979) High density lipoprotein cholesterol and incidence of coronary heart disease. The Israeli ischemic heart disease study. J Epidemiol 109: 296–309.
Castelli W P, Doyle J T, Gordon T, Hames C G, Hjortland M C, Hulley S B et al (1977) HDL cholesterol and other lipids in coronary heart disease: The cooperative lipoprotein phenotyping study. Circulation 55: 767–772.
Miller N E, Thelle D S, Forde O H, Mjos O D (1977) The Tromso heart-study. High density lipoprotein and coronary heart-disease: A prospective case-control study. Lancet 1: 965.
Ballantyne F C, Clark R S, Simpson H S, Ballantyne D (1982) High density and low density lipoprotein subfractions in survivors of myocardial infarction in the control subjects. Metabolism 31: 433–437.
Keys A (1980) Alpha lipoprotein (HDL) cholesterol in the serum and the risk of coronary heart disease and death. Lancet 2: 603–606.
Cardus D, Ribas-Cardus F, McTaggart W G (in press) Coronary risk in SCI. Its assessment by a multivariate approach. Arch Phys Med Rehabil.
Manual of Laboratory Operations (1974) Lipids Research Clinics Program. Vol. I. Lipids and Proteins Analysis. DHEW Publication (NIH): 75–628.
The Lipid Research Clinics (1980) Population Studies Data Book. Vol. 1. The Prevalence Study. US Department of Health and Human Services. Public Health Service. National Institutes of Health Publication No. 80-1527.
Walonick D S (1985) Statpac. Statistical analysis package. University of Manitoba.
Miller G J, Miller N E (1975) Plasma-high-density-lipoprotein concentration and development of ischemic heart disease. Lancet 1: 16–19.
Gofman J W, Young W, Tandy R (1966) Ischemic heart disease, atherosclerosis, and longevity. Circulation 34: 679–697.
Medalie J H, Kahn H a, Neufeld H N et al (1973) Five year myocardial infarction incidence - II. Association of single variables by age and birthplace. J Chron Dis 26: 329–349.
Castelli W P, Doyle J T, Gordon T et al (1975) HDL-cholesterol levels (HDL-c) in coronary heart disease (CHD) - A cooperative lipoprotein phenotyping study. Circulation 51/52(S II): 97.
Rhoads G L, Gulbrandsen C L, Kagan A (1976) Serum lipoproteins and coronary heart disease in a population study of Hawaii Japanese men. N Engl J Med 294: 293–298.
Hsia S L, Chao Y S, Henekens C H, Reader W B (1975) Decreased serum cholesterol-binding reserve in premature myocardial infarction. Lancet 2: 1000.
Carew T E, Kowdhinwky T, Hayes S B, Steinberg D (1976) A mechanism by which high-density proteins may slow the atherogenic process. Lancet 1: 1315.
Hartung G H, Foreyt J P, Reeves R S, Krock L P, Patsch W, Patsch J R et al (1990) Effect of alcohol dose on plasma lipoprotein subfractions and lipolytic enzyme activity in active and inactive men. Metabolism 39: 81–86.
Hartung G H, Reeves R S, Foreyt J P, Patsch W, Gotto A M (1986) Effect of alcohol intake and exercise on plasma high-density lipoprotein cholesterol subfractions and apolipoprotein A-l in women. Am J Cardiol 58: 148–151.
Hartung G H (1984) Diet and exercise in the regulation of plasma lipids and lipoproteins in patients at risk of coronary disease. Sports Med 1: 413–418.
Hartung G H, Foreyt J P, Mitchell R E, Mitchell J G, Reeves R S, Gotto A M (1983) Effect of alcohol intake on high-density lipoprotein cholesterol levels in runners and inactive men. J Am Med Assoc 249: 747–450.
Hartung G H, Foreyt J P, Mitchell R E, Vlasek I, Gotto A M (1980) Relation of diet to high-density-lipopro-tein cholesterol in middle-aged marathon runners, joggers, and inactive men. N Engl J Med 302: 357–361.
Hicks A L, MacDougall J D, Muckle T J (1987) Acute changes in high-density lipoprotein cholesterol with exercise of different intensities. J Appl Physiol 63: 1956–1960.
Hulley S B, Gordon S (1981) Alcohol and high-density lipoprotein cholesterol: Causal inference from diverse study designs. Circulation 64(S3) 57–62.
Willett W, Hennekens C H, Siegel A J, Adner M M, Castelli W P (1978) Alcohol consumption and high-density lipoprotein cholesterol in marrathon runners. TV Engl J Med 303: 1159–1161.
Tell G S (1991) Cigarette smoking, lipids, lipoproteins, and extracraneal carotid artery atherosclerosis. (Editorial). Mayo Clin Proc 66: 327–331.
Le C T and Price M (1982) Survival from spinal cord injury. J Chron Dis 35: 487–492.
Trieschmann R B, editor (1987) Aging with a Disability. Demos Publications, New York.
Freed M M, Bakst H J, Barre D C (1966) Life expectancy, survival rates and causes of death in civilian patients with spinal cord trauma. APMR 47: 457–463.
Geisler W O, Jousse A T, Wynne-Jones M, Breithampt D (1983) Survival in traumatic spinal cord injury. Paraplegia 21: 364–373.
Hackler R H (1977) A 25-year prospective mortality study in the spinal cord injured patient: Comparison with the long term living paraplegia. J Urol 117: 486–488.
Kiwerski J, Weiss M, Chrostowska T (1981) Analysis of mortality of patients after cervical spine trauma. Paraplegia 19: 347–351.
Nyquist R H, Bors E (1967) Mortality and survival in traumatic myelopathy during nineteen years, from 1946 to 1965. Paraplegia 5: 22–48.
Price M (1973) Causes of death in 11 of 227 patients with traumatic spinal cord injury over period of nine years. Paraplegia 11: 217–220.
Sneddon D G, Bedbrook G (1982) Survival following traumatic tetraplegia. Paraplegia 20: 201–207.
Young J S, Burns P E, Bower A M, McCutchens R, editors (1982) Spinal Cord Injury Statistics: Experience of the Regional Spinal Cord Injury Systems. The Good Samaritan Medical Center, Phoenix, Arizona.
Tribe C R (1963) Causes of death in the early and late stages of paraplegia. Paraplegia 1: 19–47.
Wilcox N E, Stauffer E S (1972) Follow-up of 423 consecutive patients admitted to the spinal cord centre, Rancho Los Amigos Hospital 1 January to 31 December 1967. Paraplegia 10: 115–122.
De Vivo M, Fine P R, Maetz H M, Stover S L (1980) Prevalence of spinal cord injury re-estimation employing life table techniques. Arch Neurol 37: 707–714.
Yekutiel M, Brooks M E, Ohry A, Yarom J, Carel R (1989) The prevalence of hypertension, ischaemic heart disease and diabetes in traumatic spinal cord injured patients and amputees. Paraplegia 27: 58–62.
Brown M S, Goldstein J L (1978) General scheme for regulation of cholesterol metabolism in mammalian cells. In: Dietschy JM, Gotto AM, Ontko JA, editors. Disturbances in Lipid and Lipoprotein Metabolism. American Physiological Society, Bethesda, MD, 173–180.
Kannel W B, Gordon T, Castelli W P (1981) Role of lipids and lipoprotein fractions in atherogenesis: The Framingham Study. Prog Lipid Res 20: 339–348.
Frantz, I D (1986) Cardiovascular risk - What should be measured? (Editorial) Mayo Clin Proc 61: 396–398.
Weinberg Richard B (1987) Lipoprotein metabolism: Hormonal regulation. Hosp Pract 22: 125–145.
Young S G, Northey S T, McCarthy B J (1988) Low plasma cholesterol levels caused by a short deletion in the apoliproteins B gene. Science 241: 591–593.
Glatz J F C, Van derVusse G J, Veerkamp J H (1988) Fatty acid-binding proteins and their physiological significance. News Physiol Sci 3: 41–43.
Gordon D J (1990) Role of circulating high-density lipoprotein and triglycerides in coronary artery disease: Risk and prevention. Endocrin Metabol Clin N Am 19(2): 299–309.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Cardús, D., Ribas-Cardús, F. & McTaggart, W. Lipid profiles in spinal cord injury. Spinal Cord 30, 775–782 (1992). https://doi.org/10.1038/sc.1992.149
Issue Date:
DOI: https://doi.org/10.1038/sc.1992.149